Skip to content

Quoin Pharmaceuticals, Ltd.

QNRX

CIK 0001671502

← back to feed
Revenue (TTM)
$0
Q1 Mar 2026
Net Income (TTM)
−$16.45M
−76.3% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.01
+98.6% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
—
Q1 Mar 2026
Net Margin
—
Q1 Mar 2026
Free Cash Flow (TTM)
—
Q1 Mar 2026
Cash
$3.12M
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
3.35B sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings